Filing Details
- Accession Number:
- 0000950170-23-049695
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-25 16:15:07
- Reporting Period:
- 2023-09-21
- Accepted Time:
- 2023-09-25 16:15:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1690585 | Dianthus Therapeutics Inc. | DNTH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1992260 | Simrat Randhawa | C/O Dianthus Therapeutics, Inc. 7 Times Square, 43Rd Floor New York NY 10036 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-21 | 2,000 | $13.20 | 2,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-09-22 | 2,000 | $13.20 | 4,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
